OXFORD, England, Nov. 17, 2025 /PRNewswire/ -- Accession Therapeutics Limited, a biopharmaceutical company developing next generation cancer immunotherapies, today announced it…
Three new immersive experiences illustrate how AI can accelerate 3D creation while keeping creators in controlBERKELEY, Calif. & TAIPEI, Taiwan--(BUSINESS…
Q1 Operational HighlightsStrong growth in Global Licensing with a 29% year-over-year increase, driven by our premium franchises Peanuts, Strawberry Shortcake…